SEC ownership of REED'S, INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001140215.

Comparable stake leader

Era Regenerative Medicine Ltd

Disclosed value leader

Era Regenerative Medicine Ltd

Comparable rows

3/34

Latest evidence

30 Jun 2026

Top shareholders Insider holders Latest transactions

Public ticker: REED on NYSE
Parsed ownership sources: 13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
Largest SEC-reported holder: Era Regenerative Medicine Ltd
Ranking: Comparable ownership first, then disclosed value
Comparable ownership rows: 3 of 34
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder: Era Regenerative Medicine Ltd
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date: 30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer CIK: 0001140215
Issuer location: Norwalk, CT

Ownership snapshot

Top shareholders of REED'S, INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Era Regenerative Medicine...

Disclosed value leader

Era Regenerative Medicine...

Comparable rows

3/34

Latest evidence

30 Jun 2026

13D/G 3/4/5 13F Lead comparable stake: 58% 31 rows are not safely comparable across share classes. 13D/G row: Era Regenerative Medicine Ltd Showing 1-8 of 34 holder rows.

Quick read

Era Regenerative Medicine Ltd leads the comparable SEC ownership view at 58%.

3 of 34 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Era Regenerative Medicine Ltd's linked filing trail.

Comparable ownership Top 3

Era Regenerative Medicine Ltd 58%

Shufen Deng 54%

WHITEBOX ADVISORS LLC 0.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 34 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Era Regenerative Medicine Ltd	13D/G 3/4/5 10%+ Owner 13D/G 3/4/5	58% Reported 13D/G · 04 Jun 2025	$53,043,803 28,214,789 shares	+$2,021,506	04 Jun 2025
Shufen Deng	13D/G 3/4/5 DENG, SHUFEN · Director 13D/G 3/4/5	54% Reported 13D/G · 20 May 2026	$15,907,672 6,363,069 shares	$0	20 May 2026
WHITEBOX ADVISORS LLC	13D/G 13D/G	0.8% Reported 13D/G · 31 Dec 2024	$484,557 257,743 shares	$0	31 Dec 2024
Union Square Park Capital Management, LLC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$1,354,393 1,220,174 shares	—	14 Nov 2024
Leon M. Zaltzman	3/4/5 Director, Other*, 10%+ Owner 3/4/5	— denominator unverified	— 18,012,117 shares	—	10 Mar 2022
James C. Bass	3/4/5 Director 3/4/5	— denominator unverified	$1,003,500 556,881 shares	—	04 Feb 2022
Thomas W. Kosler	3/4/5 Director 3/4/5	— denominator unverified	$932,202 517,315 shares	—	01 Jul 2022
Lewis Jaffe	3/4/5 Director 3/4/5	— denominator unverified	$720,022 399,568 shares	—	04 Feb 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 06 Nov 2025.

Buys

Insiders: 0

Sells

Insiders: 0

Net

Shares: 0

Window

Last 12 months

4 rolling buckets

Buy value Sell value

Shares: 0 Shares: 0

Window (months)	Buy value	Sell value	Net value
0-3	$0	$0	$0
3-6	$0	$0	$0
6-9	$0	$0	$0
9-12	$0	$0	$0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-20 of 26 reporting-owner rows connected to REED'S, INC.. Open a relationship link for the CIK-to-CIK filing trail.

Rows

Largest Forms 3/4/5 holder

Union Square Park Capital Management, LLC

Net 12M change

Latest report

27 Apr 2026

Name	Relationship	Holdings Value	Valuation	Report Date
Union Square Park Capital Management, LLC	10%+ Owner	$1,354,393	Filing P/S	14 Nov 2024
James C. Bass	Director	$1,003,500	Mixed	04 Feb 2022
Thomas W. Kosler	Director	$932,202	Mixed	01 Jul 2022
Lewis Jaffe	Director	$720,022	Mixed	04 Feb 2022
Thomas J. Spisak	Cfo	$686,052	Mixed	30 Sep 2021
Shufen Deng	Director	$599,999	Filing P/S	31 Dec 2024
Louis Imbrogno Jr.	Director	$576,883	Mixed	04 Feb 2022
John Bello	Director	$388,164	Mixed	10 Sep 2024
Norman E. Snyder Jr.	CEO, Director	$179,964	Mixed	29 Apr 2024
Rhonda Kallman	Director	$144,780	Mixed	04 Feb 2022
Joann Christine Tinnelly	Cfo	$68,539	Mixed	29 Apr 2024
Christopher Scott Burleson	Cco	$52,923	Mixed	29 Apr 2024
Neal Cohane	Chief Operating Officer	$675	Mixed	05 Jan 2026
Damian Francis Warshall	Chief Operating Officer		Mixed	27 Apr 2026
Douglas W. McCurdy	Cfo		Mixed	10 Feb 2025
Sam van	Director		Mixed	21 Oct 2024
Era Regenerative Medicine Ltd	10%+ Owner		Mixed	04 Jun 2025
Yumin Dai	Reed's (Asia) Exec Officer		Mixed	22 Jan 2025
Rudolf Johannes Maria Bakker	Director		Mixed	14 Apr 2025
Leon M. Zaltzman	Director, Other*, 10%+ Owner		Mixed	10 Mar 2022

Recent insider transactions for REED'S, INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares owned	Date	Ownership
Neal Cohane	REED	Common Stock					0	675	05 Jan 2026	Direct

^* marks a reported price that did not pass the local price check.